Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

Autor: Tinterri, C., Gentile, D., Gatzemeier, W., Sagona, A., Barbieri, E., Testori, A., Errico, V., Bottini, A., Marrazzo, E., Dani, C., Dozin, B., Boni, L., Bruzzi, P., Fernandes, B., Franceschini, D., Spoto, R., Torrisi, R., Scorsetti, M., Santoro, A., Canavese, G., Custodero, O., Troilo, V. L., Taffurelli, M., Cucchi, M. C., Galluzzo, V., Cabula, C., Cabula, R., Lazzaretti, M. G., Caruso, F., Castiglione, G., Grossi, S., Tavoletta, M. S., Rossi, C., Curcio, A., Friedman, D., Fregatti, P., Magni, C., Tazzioli, G., Papi, S., Giovanazzi, R., Chifu, C., Bettini, R., Pezzella, M., Michieletto, S., Saibene, T., Roncella, M., Ghilli, M., Sibilio, A., Cariello, A., Coiro, S., Falco, G., Meli, E. Z., Fortunato, L., Ciuffreda, L., Murgo, R., Battaglia, C., Rubino, L., Biglia, N., Bounous, V., Rovera, F. A., Chiappa, C., Pollini, G., Mirandola, S., Meneghini, G., Di Bartolo, F.

The SINODAR-ONE trial is a prospective noninferiority multicenter randomized study aimed at assessing the role of axillary lymph node dissection (ALND) in patients undergoing either breast-conserving surgery or mastectomy for T1-2 breast cancer (BC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb4771ac2713a7c6bd6ece3fddd60c90
https://hdl.handle.net/2318/1904537

Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project.

Autor: Cazzaniga ME; Phase 1 Research Unit & Oncology Unit, Azienda Socio Sanitaria Territoriale Monza & Milano Bicocca School of Medicine and Surgery, Monza, Italy. Electronic address: marina.cazzaniga@asst-monza.it., Giordano M; Oncology Unit, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy., Bandera M; Farmacie Sant'Agata, Pharmacy Group, Bulgarograsso (Como), Italy., Cassani C; Department of Obstetrics and Gynecology, Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Matteo, Pavia, Italy., Bounous V; Department of Obstetrics and Gynecology, Mauriziano 'Umberto I' Hospital, University of Turin, Turin, Italy., Lania A; Endocrinology, Diabetology and Andrology Unit, Biomedicine Department, Humanitas University, Milan, Italy., Biasi G; Prevention Department, Unità Operativa Complessa Medicine and Sport and Exercise, Treviso, Italy., Destro M; Medical Unit, Azienda Socio Sanitaria Territoriale Bergamo Ovest, Treviglio (BG) Italy., Ricci S; Executive Chef, Joja Restaurant, Milan, Italy., Lucini D; Exercise Medicine Unit, University of Milan BIOMETRA Department, Humanitas Clinical and Research Center, Milan, Italy., Biglia N; Department of Obstetrics and Gynecology, Mauriziano 'Umberto I' Hospital, University of Turin, Turin, Italy., Pagani O; EOC Istituto Oncologico della Svizzera Italiana Ospedale Regionale Bellinzona e Valli 6500, Bellinzona, Switzerland.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2021 Oct; Vol. 21 (5), pp. e547-e560. Date of Electronic Publication: 2021 Feb 01.

Early Breast Cancer Detection Based on Deep Learning: An Ensemble Approach Applied to Mammograms.

Autor: Khourdifi, Youness¹ (AUTHOR) y.khourdifi@usms.ma, El Alami, Alae² (AUTHOR), Zaydi, Mounia³ (AUTHOR) mounia.zaydi@junia.com, Maleh, Yassine⁴ (AUTHOR) y.maleh@usms.ma, Er-Remyly, Omar⁵ (AUTHOR) o.er-remyly@uhp.ac.ma

Publikováno v: BioMedInformatics. Dec2024, Vol. 4 Issue 4, p2338-2373. 36p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial.

Autor: Bravaccini S; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Bronte G; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Scarpi E; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, 47014, Italy., Ravaioli S; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Maltoni R; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Mangia A; Functional Biomorphology Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Tumedei MM; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Puccetti M; Azienda Unità Sanitaria Locale (AUSL) Imola, Imola, Italy., Serra P; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Gianni L; Department of Medical Oncology, Infermi Hospital, Rimini, Italy., Amaducci L; Department of Onco-hematology, Faenza Hospital, Faenza (RA), Italy., Biglia N; Division of Gynecology and Obstetrics, Department of Surgical Sciences, Umberto I Hospital, School of Medicine, University of Torino, Torino, Italy., Bounous V; Division of Gynecology and Obstetrics, Department of Surgical Sciences, Umberto I Hospital, School of Medicine, University of Torino, Torino, Italy., Paradiso AV; Institutional BioBank, Experimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Silvestrini R; Istituto Oncologico Romagnolo (IOR) Forlì, Italy., Amadori D; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy., Rocca A; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Feb 27; Vol. 12, pp. 1758835919888999. Date of Electronic Publication: 2020 Feb 27 (Print Publication: 2020).